Double-Dose radiation attack shows promise for tough childhood cancer
NCT ID NCT00083135
First seen Apr 25, 2026 · Last updated Apr 28, 2026 · Updated 2 times
Summary
This early-phase study tested a new approach for children with neuroblastoma that did not respond to standard treatments. It used two doses of a radioactive drug (I-MIBG) to target cancer cells, followed by a stem cell transplant to restore healthy blood cells. The goal was to find the safest highest dose and see if it could control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital Boston
Boston, Massachusetts, 02115, United States
-
Children's Hospital Los Angeles
Los Angeles, California, 90027-0700, United States
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229-3039, United States
-
Indiana University Cancer Center
Indianapolis, Indiana, 46202-5289, United States
-
UCSF Comprehensive Cancer Center
San Francisco, California, 94143, United States
-
University of Wisconsin Comprehensive Cancer Center
Madison, Wisconsin, 53792-6164, United States
Conditions
Explore the condition pages connected to this study.